Drug recall · August 22, 2012
DEPO-TESTOSTERONE recall
Why: Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
DEPO-TESTOSTERONE, MDV, 10ML** 200MG/ML INJECTABLE 10 ML (1 PRODUCT)
- Lots / codes
Rx #'s:C0388707 C0393621 C0397891 C0397894 C0397896 C0397905 C0404812 C0405366 C0407575
- Quantity
- 9 units
- Company
- Franck's Lab Inc., d.b.a. Franck's Compounding Lab, Ocala, FL
- Distribution
- Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies
- Initiated
- May 25, 2012 · Voluntary: Firm initiated
- Classified
- August 10, 2012
- Reported
- August 22, 2012
- Ended
- August 13, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Testosterone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.